NCI Genomic Characterization Centers

Acquire high-resolution, systematic, comprehensive (genome-wide) characterization services of cancer-related genomic alterations. The contractor(s) shall function as a fundamental resource and play a key role in the CCG research programs. Key goals shall include ensuring that standards are developed, implemented, continually improved, and maintained to support the entire genomic characterization pipeline. Study variables shall be minimized with rigorous Quality Assurance/Quality Control of all parts of the operation.

The biomaterial for these studies (DNA, RNA, or Protein) will be provided by the Biospecimen Processing Centers (BPC) of CCG. The aim is to have all molecular characterizations conducted on biomolecules from the same biospecimens for optimal analytical integration for data comparability.